Outpatient CAR T-Cell Therapy in Action

Outpatient administration of CAR T-cell therapy can increase patient satisfaction, improve quality of life during treatment, and conserve inpatient resources, according to David Porter, MD, director of Cell Therapy and Transplantation at the Abramson Cancer Center, where over 94 percent of patients receiving Kymriah for lymphoma were treated as outpatients.